Dr. Lululun Co., Ltd. and Japan Pressure Ulcer Society Kyushu-Okinawa Regional Meeting Co-host Seminar Proposing Next-Generation Skincare Based on Clinical Insights
Key facts
- Dr. Lululun Co., Ltd. and Japan Pressure Ulcer Society Kyushu-Okinawa Regional Meeting Co-host Seminar Proposing Next-Generation Skincare Based on Clinical Insights
- Dr. Lululun Co., Ltd., operator of Japan's No.1 face mask brand 'Lululun,' co-hosted a seminar with the Japan Pressure Ulcer Society Kyushu-Okinawa Regional Meeting on May 9, 2026, presenting cutting-edge research on wound healing and next-generation skincare technologies.
- Source: PR TIMES
- Date: Thu Jun 18 2026 03:00:01 GMT+0900 (Japan Standard Time)
Direct answer
Dr. Lululun Co., Ltd., operator of Japan's No.1 face mask brand 'Lululun,' co-hosted a seminar with the Japan Pressure Ulcer Society Kyushu-Okinawa Regional Meeting on May 9, 2026, presenting cutting-edge research on wound healing and next-generation skincare technologies.
- Citation
- Dr. Lululun Co., Ltd. and Japan Pressure Ulcer Society Kyushu-Okinawa Regional Meeting Co-host Seminar Proposing Next-Generation Skincare Based on Clinical Insights (Thu Jun 18 2026 03:00:01 GMT+0900 (Japan Standard Time)), PR TIMES
- Source
- PR TIMES
- Date
- Thu Jun 18 2026 03:00:01 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
Dr. Lululun Co., Ltd., operator of Japan's No.1 face mask brand 'Lululun,' co-hosted a seminar with the Japan Pressure Ulcer Society Kyushu-Okinawa Regional Meeting on May 9, 2026, presenting cutting-edge research on wound healing and next-generation skincare technologies.
AI Analysis
Frequently Asked Questions
- Q: What was the main purpose of this seminar?
- A: To share scientific insights on pressure ulcer treatment and daily skincare, promoting medical-beauty collaboration.
- Q: What are the main effects of 5-ALA?
- A: It activates mitochondria and enhances ATP production to support cell regeneration.
- Q: What is special about the Sei-Kankaku Sheet?
- A: Its multi-layer structure delivers moisture deep into the stratum corneum with daily-safe formulation.
- Q: What are the future plans?
- A: To develop medical wound dressings through preclinical trials and RCTs.
- Q: Who presented at the seminar?
- A: Dr. Natsumi Noguchi and Hinano Sasaki from Dr. Lululun Co., Ltd.